Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an update.
Syngene International Ltd. has announced a scheduled meeting with Goldman Sachs on November 28, 2025, in Mumbai. This meeting is part of their ongoing engagement with analysts and institutional investors, and the company has assured that no unpublished price-sensitive information will be disclosed during the meeting.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology industry, providing integrated research, development, and manufacturing services across various sectors, including pharmaceuticals, biotechnology, and agrochemicals. The company is based in Bengaluru, India, and focuses on delivering customized solutions to its global clientele.
Average Trading Volume: 64,839
Technical Sentiment Signal: Sell
Current Market Cap: 253.7B INR
For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.